Clinical Trials Browser

Phase 3 × INDUSTRY × Neoplasm, Residual × Clear all

NCT05232916 2026-06-04

FLAMINGO-01

Phase 3 Recruiting

Breast Neoplasms, Neoplasm, Residual

NCT03512197 2023-08-21

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Phase 3 Completed

511 enrolled 26 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual